Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR). https://gardp.org/this-is-big/https://bsky.app/profile/gardp.bsky.socialhttps://bsky.app/profile/gardp.bsky.social/post/3mzddyqtbnc2v🎂 Congratulations to MPP on 10 years of MedsPaL! Glad to have collaborated with @medicinespatentpool.org on patent assessments of two priority antibiotics to help advance access, affordability and availability in LMICs. #AccessToMedicines #Antibiotics [contains quote post or other embedded content]02 Nov 2026 12:43 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mzddyqtbnc2vhttps://bsky.app/profile/gardp.bsky.social/post/3mzcqsjpdyv2t📚 8 new terms have been added to the REVIVE Encyclopaedia, covering key concepts in antibiotic research, clinical trials and infectious disease treatment. Explore the latest entries and strengthen your understanding of antibiotic development and use. https://gardp.pulse.ly/d8j8alxn8g #AMR #REVIVE02 Nov 2026 06:59 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mzcqsjpdyv2thttps://bsky.app/profile/gardp.bsky.social/post/3mz4335ufgc2v"Countries must align all policies, including trade and intellectual property policies, with the goal of realizing the right to health." Speaking at the 2026 UN Human Rights Council Social Forum, GARDP's Peter Beyer, moderated a panel on equitable access to medicines, vaccines and health products.30 Oct 2026 15:14 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mz4335ufgc2vhttps://bsky.app/profile/gardp.bsky.social/post/3mz34bfz3xp2q🤝 International partners met in Berlin last week to strengthen Ukraine’s response to antimicrobial resistance (AMR), with support from GARDP. #AMR #AntimicrobialResistance #Ukraine30 Oct 2026 06:03 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mz34bfz3xp2qhttps://bsky.app/profile/gardp.bsky.social/post/3myyowuutry2w💊What does a bigger response to drug-resistant infections look like? For GARDP, it's: 🧪Co-developing BWC0977 with Bugworks Research to tackle Gram-negative bacteria. 🌍Expanding access to cefiderocol for serious infections. #AMRIsBIG #OurResponseIsBigger 🔗 https://tinyurl.pulse.ly/b9zhend2d229 Oct 2026 06:59 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myyowuutry2whttps://bsky.app/profile/gardp.bsky.social/post/3mywhlujirr2a📺 Missed our webinar? Watch our latest webinar to hear experts discuss the barriers to antibiotic access in high-burden settings and the approval of zoliflodacin in Thailand just six months after US FDA approval. 🎥 https://youtu.pulse.ly/vytadx0fcg28 Oct 2026 09:43 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mywhlujirr2ahttps://bsky.app/profile/gardp.bsky.social/post/3myu56umsyk27🎉 Big congratulations to DNDi on this important milestone! It’s great to see the Alliance grow, bringing together more institutions across dengue-endemic countries to move research forward and expand treatment options. [contains quote post or other embedded content]27 Oct 2026 11:31 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myu56umsyk27https://bsky.app/profile/gardp.bsky.social/post/3mytkwypwlk2kIn a 🆕 #REVIVE Antimicrobial Viewpoint, Dr Teodora Elvira C. Wi examines the growing threat of drug-resistant gonorrhoea, from ceftriaxone resistance to the promise of new antibiotics, better diagnostics and vaccines. 🔗Read the full Viewpoint: https://revive.gardp.org/antimicrobial-resistance-in-neisseria-gonorrhoeae-tipping-point-between-therapeutic-failure-and-scientific-innovation/27 Oct 2026 06:04 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mytkwypwlk2khttps://bsky.app/profile/gardp.bsky.social/post/3myragjfnys25Too many antibiotics in development are variations of existing treatments. Tackling antimicrobial resistance demands genuine innovation. GARDP focuses antibiotic R&D on WHO priority pathogens, directing innovation towards the greatest unmet needs & public health impact. #AMR #AntibioticResistance26 Oct 2026 07:51 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myragjfnys25https://bsky.app/profile/gardp.bsky.social/post/3myjk4dxvi22yAt a recent national consultation in Delhi, GARDP, IIPH-Delhi and PHFI brought stakeholders together to advance a Strategic Roadmap for India, co-convened with FICCI, with ICMR as technical and advisory partner. #ResponsibleAccess #AMR23 Oct 2026 06:23 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myjk4dxvi22yhttps://bsky.app/profile/gardp.bsky.social/post/3myhodjfvbc2cREVIVE resources are now featured in PACE’s Therapeutics Resources Directory, a curated collection of webinars, guidance, databases and practical tools covering the journey from early discovery to regulatory approval. 🔗https://paceamr.org.uk/therapeutics-resources-directory/22 Oct 2026 12:33 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myhodjfvbc2chttps://bsky.app/profile/gardp.bsky.social/post/3myepdvlxxk2g💊As resistance grows, yesterday’s antibiotics may fall short. GARDP is working to expand options for gonorrhoea with zoliflodacin, a first-in-class, single-dose oral antibiotic, and working to expand global access to new treatments. AMR is BIG. Our response is BIGGER. 🔗 tinyurl.com/e3thex7y21 Oct 2026 08:13 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myepdvlxxk2ghttps://bsky.app/profile/gardp.bsky.social/post/3myclqcfbhs2e🌍At #WHS2026 in Berlin, global leaders confronted urgent questions around financing, country leadership and health innovation's future. GARDP Board Chair Glenda Gray makes the case for keeping #AMR, and investment in new antibiotics, firmly on the global agenda. @worldhealthsummit.bsky.social20 Oct 2026 12:03 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myclqcfbhs2ehttps://bsky.app/profile/gardp.bsky.social/post/3myc44ow5ls2uAt #IUSTI2026 in Prague, GARDP and partners explored how evidence on antimicrobial resistance, disease burden, health economics and patient pathways can inform policy and clinical practice. #Gonorrhoea #AMR #Zoliflodacin20 Oct 2026 07:24 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3myc44ow5ls2uhttps://bsky.app/profile/gardp.bsky.social/post/3mya2sre5l22bA new joint perspective paper from GARDP, @dndi.org, @mmv.org and MDGH sets out 7 recommendations to strengthen the WHO functions that support needs-driven R&D and access, particularly where commercial incentives are limited. 📄 https://gardp.org/strengthening-whos-role-in-public-health-innovation-a-pdp-perspective/19 Oct 2026 11:55 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mya2sre5l22bhttps://bsky.app/profile/gardp.bsky.social/post/3mxylwpnets2o📅 Abstract deadline: 16 Nov 2026, 17:00 GMT Antimicrobial chemotherapy researchers are invited to submit abstracts to #ACC2027, a free, virtual conference on #AMR organised by @bsacandjac.bsky.social and GARDP with @eupohamr.bsky.social as the 2027 collab org. 👉 acc-conference.com#posters16 Oct 2026 12:40 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxylwpnets2ohttps://bsky.app/profile/gardp.bsky.social/post/3mxxtgtlcss2dICMR and GARDP convened leading voices from India's health ecosystem to set priorities for tackling #AMR in India. The consultation will help shape GARDP’s 2027–2031 strategy for India, identifying opportunities to improve access to antibiotics and accelerate the development of new treatments.16 Oct 2026 05:22 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxxtgtlcss2dhttps://bsky.app/profile/gardp.bsky.social/post/3mxnvf3lmuc2v📹Herman Goossens, Emeritus Professor at the University of Antwerp, explains why sustained investment in R&D, clinical trials, manufacturing and equitable access is essential to secure the future of antibiotics. #AMRIsBig #OurResponseIsBigger12 Oct 2026 06:30 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxnvf3lmuc2vhttps://bsky.app/profile/gardp.bsky.social/post/3mxja6eaaa22qA new #REVIVE antimicrobial viewpoint examines China’s experience translating AMR policy into practice, and what its progress, persistent gaps and approach to stewardship, One Health and antimicrobial innovation can teach us about implementation at scale. 🔗 https://revive.gardp.org/the-current-amr-landscape-in-china-and-how-the-healthcare-systems-and-national-action-plan-operate-in-practice/10 Oct 2026 10:00 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxja6eaaa22qhttps://bsky.app/profile/gardp.bsky.social/post/3mxgwvyekgk2wLord Darzi hosted a working lunch at the House of Lords this week, convened with GARDP, in his new role as GARDP Advocate. Guests from Parliament, government, the NHS, research and industry discussed AMR resilience, financing and partnership. #AMR09 Oct 2026 12:09 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxgwvyekgk2whttps://bsky.app/profile/gardp.bsky.social/post/3mxdrjnthps2t📢 We’re hiring ! Join GARDP to lead strategy and delivery across R&D, access and partnerships, advancing new and existing antibiotics for serious bacterial infections. 🔗 https://apply.workable.com/gardp/j/A112C71D79 #Hiring #GARDP #AMR08 Oct 2026 05:54 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxdrjnthps2thttps://bsky.app/profile/gardp.bsky.social/post/3mxbzakbm722zAt the 63rd PAHO Directing Council, Member States approved the Plan of Action on AMR 2027–2031. GARDP and PAHO’s work on surveillance, diagnostics, Reserve antibiotic access and R&D supports the Plan’s priorities. We look forward to contributing to its implementation. 🔗https://tinyurl.com/yvs8ryxd07 Oct 2026 13:07 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mxbzakbm722zhttps://bsky.app/profile/gardp.bsky.social/post/3mx6szqz6pc2kNew gonorrhoea treatments need a clear pathway from evidence to policy and practice. At #IUSTI2026, GARDP and partners will discuss the evidence needed to guide responsible introduction and maximise public health impact. 📍 South Hall 2A 📅 16 Oct, 13:00–14:25 #AMR06 Oct 2026 06:38 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mx6szqz6pc2khttps://bsky.app/profile/gardp.bsky.social/post/3mwx47rdthk2c 🤝In 2026, #REVIVE welcomes 19 new experts to its global community, bringing expertise across infectious diseases, microbiology, epidemiology, drug discovery, clinical research, regulatory affairs and #AMR. Different expertise. Diverse perspectives. One shared commitment: tackling AMR.03 Oct 2026 05:01 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mwx47rdthk2chttps://bsky.app/profile/gardp.bsky.social/post/3mwuqgat72k2mWhat if antibiotic access focused not on overuse vs underuse, but optimal use? 📅Join GARDP on 27 Oct, 12:00 PM CET to explore how effective treatments can reach high-burden populations and lessons from zoliflodacin’s Thailand approval. 🔗 Register: tinyurl.com/3xfm77hc @advance-id.bsky.social02 Oct 2026 06:25 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mwuqgat72k2mhttps://bsky.app/profile/gardp.bsky.social/post/3mwsqay5rys24🌍 “Innovation doesn’t happen in silos.” At #GAMRIC2026 in Lisbon, Peter Beyer reflects on why GARDP supports this conference: creating space to exchange ideas, find partners and connect work across the @=#AMR field. Next stop: 📍Bangalore, India 📆7–9 Sept 202701 Oct 2026 11:16 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mwsqay5rys24https://bsky.app/profile/gardp.bsky.social/post/3mwncgndqkc2k🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.29 Sep 2026 07:26 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mwncgndqkc2khttps://bsky.app/profile/gardp.bsky.social/post/3mwlfql3sqc2s🌎 For the first time, GARDP is participating in the PAHO Directing Council, joining health authorities from across the Americas to discuss shared public health priorities. 💊Our work with PAHO is strengthening AMR surveillance, research and antibiotic access. 🎥See the work taking shape in LatAm.28 Sep 2026 13:20 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mwlfql3sqc2shttps://bsky.app/profile/gardp.bsky.social/post/3mw3xbaccmk2c🚀 #GAMRIC2026 kicks off in Lisbon For the next three days, people working across #AMR are coming together to talk about what is changing in the science, where the gaps remain, and what it will take to develop better tools against AMR. Come meet the team!22 Sep 2026 09:51 +0000at://did:plc:6ohydvsnh2j4lbvm4lp6ec4e/app.bsky.feed.post/3mw3xbaccmk2c